Moolec Science (MLEC) Cash from Investing Activities (2023 - 2024)
Moolec Science (MLEC) reported Cash from Investing Activities of -$10.0 million for Q4 2024, up 1.39% on a YoY basis from -$9.8 million in Q1 2024, and down 16615.14% sequentially from -$59738.0 in Q3 2024.
Moolec Science (MLEC) Cash from Investing Activities (2023 - 2024) Analysis & Trends
Moolec Science (MLEC) has 2 years of Cash from Investing Activities data on file, last reported at -$10.0 million in Q4 2024.
- For the quarter ending Q4 2024, Cash from Investing Activities rose 1.39% year-over-year to -$10.0 million; the trailing twelve-month figure through Dec 2024 stood at -$37.5 million (down 5.69% YoY), and the FY2025 full-year result was -$36.0 million, down 31.34% from the prior year.
- Cash from Investing Activities eased to -$10.0 million in Q4 2024, from -$59738.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $174563.0 in Q3 2023 to a low of -$27.6 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,440.76 Bn | 66,440.47 Bn | - | - |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 468.28 Bn | 463.49 Bn | 1.35 Bn | -45.51 Mn |
| 5 | Vertex Pharmaceuticals | 122.49 Bn | 115.24 Bn | 2.59 Bn | -431.90 Mn |
| 6 | Regeneron Pharmaceuticals | 70.26 Bn | 61.51 Bn | 3.31 Bn | -428.90 Mn |
| 7 | Belite Bio | 62.88 Bn | 62.88 Bn | - | - |
| 8 | Argenx Se | 55.67 Bn | 50.48 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.37 Bn | 34.36 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -9.99 Mn |
| Dec 31, 2024 | -9.99 Mn |
| Sep 30, 2024 | -59,738.00 |
| Sep 30, 2024 | -59,738.00 |
| Jun 30, 2024 | -27.56 Mn |
| Jun 30, 2024 | -27.56 Mn |
| Mar 31, 2024 | 112,476.00 |
| Mar 31, 2024 | 112,476.00 |
| Dec 31, 2023 | -10.13 Mn |
| Dec 31, 2023 | -10.13 Mn |
| Sep 30, 2023 | 174,563.00 |
| Sep 30, 2023 | 174,563.00 |
| Jun 30, 2023 | -25.44 Mn |
| Jun 30, 2023 | -25.44 Mn |
| Mar 31, 2023 | -82,344.00 |
| Mar 31, 2023 | -82,344.00 |